Yoshioki Yamasaki

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis

Yoshioki Yamasaki, Hisakata Yamada, Masaomi Yamasaki et al. · Lara D. Veeken · 2006 · 208 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan

Yoshioki Yamasaki, Hidehiro Yamada, Michiko Ohkubo et al. · The Journal of Rheumatology · 2011 · 134 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +5

Unusually high frequency of autoantibodies to PL‐7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis

Yoshioki Yamasaki, Hidehiro Yamada, Toshiko Nozaki et al. · Arthritis & Rheumatism · 2006 · 113 citations

Life Sciences, Immunology, Internal Medicine +14

Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis

Kohei Azuma, Hidehiro Yamada, Michiko Ohkubo et al. · Modern Rheumatology · 2010 · 84 citations

Medicine, Dermatology, Internal Medicine +16